Näär Lab

Lab Press Releases

UC Berkeley Scientists create an experimental Covid treatment

August 9th. 2022
CBS Bay Area

KPIX 5’s Amanda Starrantino talks to Dr. Anders Naar, professor of Metabolic Biology at UC Berkeley on their latest experimental therapeutic treatment for Covid that could eventually make treatment easier.

New COVID Therapeutic Being Tested

August 8th, 2022
NBC Bay Area

“A nasal spray being developed at UC Berkeley may be a potential game changed in the fight against COVID…”

New inhaled COVID-19 therapeutic blocks viral replication in the lungs

August 8th, 2022

“In a new study published online in the journal Nature Communications, the team shows that these short snippets, called antisense oligonucleotides (ASOs), are highly effective at preventing the virus from replicating in human cells…”

COVID-19 Research Spotlight: Anders Näär on Preventing Infection with Molecular Velcro

April 12th, 2021

“ASOs are like molecular Velcro that binds the RNAs, preventing them from working. When COVID hit, we decided to see if we can use ASO technology to target SARS-CoV-2, the virus that causes COVID-19, because its genome is made of RNA…”

Researchers discover link between microRNA and metabolic disorders

October 23rd, 2020

“The results were quite striking,” said Näär. “They show that a microRNA acting as a master regulator of the energy storage programs in many metabolically active organs may contribute to metabolic diseases…”

Scientists pivot to COVID-19 research, hoping for quick results to deal with pandemic

May 19th, 2020

“There is a tremendous amount of interest in health sciences at UC Berkeley, and that is reflected in these COVID-19 efforts,” said Näär…

Insulin Insights

April 4th, 2019

“Now, professor Anders Näär and collaborators from Harvard Medical School (HMS) have made key new insights into the molecular behavior of insulin….”